X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Fresenius Kabi Onco. Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Fresenius Kabi Onco. Quarterly Results   (DBPH)

Here are the latest quarterly results of Fresenius Kabi Onco.. For more details, see the Fresenius Kabi Onco. financial fact sheet and Fresenius Kabi Onco. share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Fresenius Kabi Onco. Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-11
3
Mar-12
3
Jun-12
3
Sep-12
3
Dec-12
3
Mar-13
3
Jun-13
3
Sep-13
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,2841,2181,3351,6452,0509321,269961 
Other income Rs m41657729550 
Turnover Rs m1,2881,2191,3411,6502,1279611,324961 
Expenses Rs m1,1471,0781,1121,1651,4378191,1841,250 
Gross profit Rs m13614022448061311385585 
Depreciation Rs m6361626467656975 
Interest Rs m165907300073 
Profit before tax Rs m61211683486237771437 
Tax Rs m17303779140872311 
Profit after tax Rs m44-9131269483-1048426 
Gross profit margin %10.611.516.829.229.912.16.760.9 
Effective tax rate %27.9142.922.022.722.5113.032.42.5 
Net profit margin %3.4-0.79.816.423.6-1.13.844.3 
Diluted EPS Rs 0.3 -0.1 0.8 1.7 3.1 -0.1 0.3 2.7  
Diluted EPS (TTM) Rs 1.6 1.4 1.6 2.7 5.5 5.5 5.0 6.0  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   GLENMARK PHARMA  DR. REDDYS LAB  ALKEM LABORATORIES  J.B.CHEMICALS  ELDER PHARMA  

Compare FRESENIUS KABI ONCO. With:   GLENMARK PHARMA  DR. REDDYS LAB  ALKEM LABORATORIES  J.B.CHEMICALS  ELDER PHARMA  

Compare FRESENIUS KABI ONCO. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Rising Crude Oil Prices, Developments in the Automobile Sector, and Top Cues in Focus Today(Pre-Open)

Indian share markets ended their trading session on a strong note yesterday. Gains were largely seen in the oil & gas sector and telecom sector.

Views on news

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

A Letter to You from India's No. 1 Trader(The 5 Minute Wrapup)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FRESENIUS KABI ONCO. SHARE PRICE


Jan 2, 2014 (Close)

TRACK FRESENIUS KABI ONCO.

  • Track your investment in FRESENIUS KABI ONCO. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON FRESENIUS KABI ONCO.

FRESENIUS KABI ONCO. - ACTAVIS COMPARISON

COMPARE FRESENIUS KABI ONCO. WITH

MARKET STATS